Dr Nicolas Tabareau from IMT Atlantique Bretagne-Pays de la Loire, provides us with further insight about interactive proof assistants, within the wider field of computer science, software and mathematics.
Mark Daly, Director of the Institute for Molecular Medicine Finland (FIMM), HiLIFE at the University of Helsinki, shares his expertise on medical genetic research on a population scale in Finland.
Dr Carlos Ziebert, head of IAM-AWP’s Calorimeter Center, KIT, explains how battery calorimetry can enhance the lifetime and safety of Lithium-ion and post-Li cells.
Dirk Beckers, Director of the Innovation and Networks Executive Agency, charts the important work of the organisation in supporting transport and energy research plus the ambitious Horizon Europe research and innovation framework programme (2021-2027).
Israeli therapeutics firm, Pluristem, have recently pioneered a breakthrough treatment which administers a unique placenta-based cell therapy to COVID-19 patients who have been identified as high-risk mortality cases.
Researchers at the University of Exeter Medical School and the University of Connecticut School of Medicine found that a faulty gene linked to dementia doubles the risk of developing severe COVID-19.
János G. Filep, MD from the University of Montreal and Maisonneuve-Rosemont Hospital in Canada, discusses targeting immune mechanisms underlying cardiovascular diseases.
The first known case of subacute thyroiditis after COVID-19 infection has been reported in a study published in The Journal of Clinical Endocrinology & Metabolism.
Jay Sibbitts, Shu Jia, Obdulia Covarrubias-Zambrano, Stefan H. Bossmann and Christopher T Culbertson from Kansas State University’s Department of Chemistry walk us through what we need to know about microfluidic devices for detecting pain.
Philippe JACQUES, Managing Director of EMIRI, explores how advanced materials can be used to solve global challenges such as the current COVID-19 pandemic.
Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explores if nanotechnology aids the battle against COVID-19.
Prashant Dogra1, Kavya Sinha2, Zhihui Wang1, Vittorio Cristini1,*
1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas
2Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart...
Researchers from The University of Manchester, Salford Royal and Res Consortium prove that over 25% of the UK are likely to have contracted COVID-19 already.
Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.
One of the key questions is soon to be answered by researchers, who will track lockdown impact on alcohol intake, gambling habits and porn watching.
Here, R.M Winglee and M. Danner, Department of Earth and Space Sciences, University of Washington, discuss robotic exploration and High-Velocity Impactors.
Studies suggest that the use of mesenchymal stem cells collected from umbilical cord blood and tissue are a safe and effective way to alleviate symptoms of coronavirus and promote fast recovery.
The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.
Researchers say we should repurpose existing drugs, which would be faster than waiting for a "magic bullet" vaccine to treat COVID-19.
Mike Fischer CBE, Founder of the COVID-19 Volunteer Testing Network, details the work being done to keep healthcare workers safe on the frontline and provide regular screening for COVID-19.